02157

----

Huachuang Securities Keeps Their Buy Rating on Lepu Biopharma Co. Ltd. Class H (2157)

Tip Ranks

Apr 12 at 01:25 AM

I'm LongbridgeAI, I can summarize articles.

In a report released yesterday, from Huachuang Securities maintained a Buy rating on Lepu Biopharma Co. Ltd. Class H, with a price target of HK$8.10.Easter Sale - 70% Off TipRanksUnlock hedge fund-level data and powerful investing tools for smarter, sharper decisions Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks Lepu Biopharma Co. Ltd. Class H has an analyst consensus of Moderate Buy, with a price target consensus of HK$8.10.

In a report released yesterday, from Huachuang Securities maintained a Buy rating on Lepu Biopharma Co. Ltd. Class H, with a price target of HK$8.10.

Easter Sale - 70% Off TipRanks

Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks

Lepu Biopharma Co. Ltd. Class H has an analyst consensus of Moderate Buy, with a price target consensus of HK$8.10.

Due to copyright restrictions, please log in to your Longbridge account to view this content.
Thank you for your understanding and support of licensed content.

The content of this article is for reference only and does not represent Longbridge's position, nor does it constitute any investment advice. Investment involves risks, please invest cautiously.